ATE458498T1 - Zellwachstumshemmer mit anti-pept-antikörper - Google Patents

Zellwachstumshemmer mit anti-pept-antikörper

Info

Publication number
ATE458498T1
ATE458498T1 AT02788719T AT02788719T ATE458498T1 AT E458498 T1 ATE458498 T1 AT E458498T1 AT 02788719 T AT02788719 T AT 02788719T AT 02788719 T AT02788719 T AT 02788719T AT E458498 T1 ATE458498 T1 AT E458498T1
Authority
AT
Austria
Prior art keywords
pept
cell growth
antibodies
growth inhibitors
cytotoxic activity
Prior art date
Application number
AT02788719T
Other languages
English (en)
Inventor
Tatsuhiko Kodama
Takao Hamakubo
Ryoichi Saitoh
Iwao Ohizumi
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE458498T1 publication Critical patent/ATE458498T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02788719T 2001-12-04 2002-12-04 Zellwachstumshemmer mit anti-pept-antikörper ATE458498T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001369608 2001-12-04
JP2002164834 2002-06-05
PCT/JP2002/012708 WO2003047621A1 (en) 2001-12-04 2002-12-04 CELL PROLIFERATION INHIBITOR CONTAINING ANTI-PepT ANTIBODY

Publications (1)

Publication Number Publication Date
ATE458498T1 true ATE458498T1 (de) 2010-03-15

Family

ID=26624860

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02788719T ATE458498T1 (de) 2001-12-04 2002-12-04 Zellwachstumshemmer mit anti-pept-antikörper

Country Status (7)

Country Link
US (1) US7666998B2 (de)
EP (1) EP1462113B1 (de)
JP (2) JPWO2003047621A1 (de)
AT (1) ATE458498T1 (de)
AU (1) AU2002354374A1 (de)
DE (1) DE60235499D1 (de)
WO (1) WO2003047621A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003033024A1 (fr) * 2001-10-16 2003-04-24 Chugai Seiyaku Kabushiki Kaisha Inhibiteur de proliferation cellulaire
AU2002354374A1 (en) 2001-12-04 2003-06-17 Chugai Seiyaku Kabushiki Kaisha CELL PROLIFERATION INHIBITOR CONTAINING ANTI-PepT ANTIBODY
EP1491631B1 (de) 2002-03-29 2013-05-08 Chugai Seiyaku Kabushiki Kaisha Screening-verfahren für transporterinhibitoren
AU2003242024A1 (en) * 2002-06-05 2003-12-22 Chugai Seiyaku Kabushiki Kaisha Method of constructing antibody
JP4551326B2 (ja) * 2003-03-28 2010-09-29 中外製薬株式会社 ペプチドトランスポーターの輸送活性を阻害する抗体
US7964767B2 (en) * 2004-03-31 2011-06-21 Chugai Seiyaku Kabushiki Kaisha Transgenic mice expressing baculovirus soluble GP64 and methods of using such mice to make antibodies
WO2016022821A1 (en) * 2014-08-06 2016-02-11 Georgia State University Research Foundation, Inc. Compositions and methods for treating colorectal cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108499A (en) 1993-02-04 2000-02-29 Lilly Co Eli Mammalian influx peptide transporter
US5500346A (en) * 1993-06-29 1996-03-19 Eli Lilly And Company Monoclonal antibodies to human influx peptide transporter
US5849525A (en) * 1994-03-09 1998-12-15 Brigham And Women's Hospital, Inc. Compositions corresponding to a proton-coupled peptide transporter and methods of making and using same
JPH08134100A (ja) 1994-11-09 1996-05-28 Unitika Ltd 糖鎖特異的抗体の製造方法
WO1997019919A1 (en) 1995-11-30 1997-06-05 C & C Research Laboratories Sulfamide derivatives
FR2761994B1 (fr) 1997-04-11 1999-06-18 Centre Nat Rech Scient Preparation de recepteurs membranaires a partir de baculovirus extracellulaires
JPH11172A (ja) 1997-06-11 1999-01-06 Snow Brand Milk Prod Co Ltd ペプチド輸送タンパク質遺伝子を含むｄｎａ、ベクター及び微生物
US6867017B1 (en) * 1998-10-23 2005-03-15 The United States Of America As Represented By The Department Of Health And Human Services ATP-binding transporter (ABC7) and methods for detection of anemia and ataxia
ATE407206T1 (de) 1998-11-10 2008-09-15 Univ Rochester Methoden zu herstellung von genbanken
JP4552056B2 (ja) 1999-11-15 2010-09-29 独立行政法人科学技術振興機構 後天的免疫寛容の獲得方法
JP2001197846A (ja) 2000-01-18 2001-07-24 Ys New Technology Kenkyusho:Kk 免疫寛容動物の作製方法
WO2003033024A1 (fr) 2001-10-16 2003-04-24 Chugai Seiyaku Kabushiki Kaisha Inhibiteur de proliferation cellulaire
AU2002354374A1 (en) 2001-12-04 2003-06-17 Chugai Seiyaku Kabushiki Kaisha CELL PROLIFERATION INHIBITOR CONTAINING ANTI-PepT ANTIBODY
EP1491631B1 (de) * 2002-03-29 2013-05-08 Chugai Seiyaku Kabushiki Kaisha Screening-verfahren für transporterinhibitoren
AU2003242024A1 (en) 2002-06-05 2003-12-22 Chugai Seiyaku Kabushiki Kaisha Method of constructing antibody
JP4551326B2 (ja) * 2003-03-28 2010-09-29 中外製薬株式会社 ペプチドトランスポーターの輸送活性を阻害する抗体
US7964767B2 (en) * 2004-03-31 2011-06-21 Chugai Seiyaku Kabushiki Kaisha Transgenic mice expressing baculovirus soluble GP64 and methods of using such mice to make antibodies

Also Published As

Publication number Publication date
EP1462113B1 (de) 2010-02-24
US20050281825A1 (en) 2005-12-22
US7666998B2 (en) 2010-02-23
AU2002354374A1 (en) 2003-06-17
JP2010013471A (ja) 2010-01-21
DE60235499D1 (de) 2010-04-08
EP1462113A1 (de) 2004-09-29
WO2003047621A1 (en) 2003-06-12
JPWO2003047621A1 (ja) 2005-04-14
EP1462113A4 (de) 2004-12-29

Similar Documents

Publication Publication Date Title
GEP20074091B (en) Cripto blocking antibodies and uses thereof
GB2368796A (en) Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
EA200200105A1 (ru) СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ;
SG150550A1 (en) Pharmaceutical preparation containing an antibody for the egf receptor
GEP20105118B (en) Anti-vegf antibodies
FI1897548T4 (fi) T-solujen säätely
NZ595450A (en) Antibodies to M-CSF
ATE381943T1 (de) Zellwachstumsinhibition
TR199902818T2 (xx) Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler.
AU9399501A (en) Therapeutic antibodies
GEP20094829B (en) Fully human antibodies against human 4-1bb (cd137)
MY139055A (en) Lyophilised preparation containing antibodies to the egf receptor
ATE355079T1 (de) Behandlung von prostata-krebs mit anti-erbb2 antikörpern
EP0724456A4 (de) Antikörper gegen cd40
TR200000756T2 (tr) Davranış bozukluğu tedavisi.
EE05140B1 (et) L„htematerjal tseeriumil p?hinevatele abrasiividele, selle tootmismeetod, tseeriumil p?hinevate abrasiivide tootmismeetod ja tseeriumil p?hinev abrasiiv
DE60230017D1 (de) Farnesyl-protein-transferase hemmer in kombination mit antiöstrogenen
EA200200808A1 (ru) Модифицированные цитокины, предназначенные для применения в терапии рака
DE60002855D1 (de) Haloalkoxy-imidazonaphthyridine
DE60235499D1 (de) ZELLWACHSTUMSHEMMER MIT ANTI-PepT-ANTIKÖRPER
EA200400930A1 (ru) Блокирующее моноклональное антитело к vla-1 или его применение для лечения воспалительных заболеваний
MXPA03000642A (es) Nuevos compuestos y su uso como inhibidores de transportes de glicina.
NZ336781A (en) Fibronectin binding protein compositions, antibodies thereto, and methods of use
EA200200798A1 (ru) Кальцилитические соединения
EP1869468A4 (de) Kolloidale metallkonjugate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties